Prospects of rivaroxaban application in treatment of patients with chronic ischemic heart disease

Prospects of rivaroxaban application in treatment of patients with chronic ischemic heart disease

The review is devoted to the analysis of the methods of hemostasis treatment in order to improve the prognosis of patients with chronic ischemic heart disease (IHD). The results of the most significant randomized clinical studies, which evaluated the effectiveness and safety of double antiplatelet t...

Full description

Bibliographic Details
Main Author:	N. B. Perepech
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2020-01-01
Series:	Медицинский совет
Subjects:	chronic ihd prognosis efficacy and safety of therapy antiaggregants rivaroxaban
Online Access:	https://www.med-sovet.pro/jour/article/view/5473

Similar Items

New Opportunities for Improving the Prognosis of Patients with Chronic Ischemic Heart Disease
by: N. B. Perepech
Published: (2020-01-01)

Hospital Admissions Due to Ischemic Heart Diseases and Prescriptions of Cardiovascular Diseases Medications in England and Wales in the Past Two Decades
by: Sara Ibrahim Hemmo, et al.
Published: (2021-07-01)

TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1)
by: S. N. Tolpygina, et al.
Published: (2015-09-01)

Bayer registered a new indication for rivaroxaban for use in patients with coronary heart disease or peripheral artery disease in the European Union and USA
by: Bayer Company Press Release
Published: (2018-11-01)

Prevalence of ischemic heart disease among urban population of Siliguri, West Bengal
by: Mandal Sukanta, et al.
Published: (2009-01-01)

RIVAROXABAN IN THE PREVENTION OF THROMBOEMBOLIC COMPLICATIONS IN PATIENTS WITH ATRIAL FIBRILLATION
by: M. Yu. Gilyarov
Published: (2015-12-01)

RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID
by: N. F. Puchinyan, et al.
Published: (2016-01-01)

Hemomediastino en tomador de rivaroxaban
by: Pablo Ruiz-Sada, et al.
Published: (2016-12-01)

Treatment application of rivaroxaban in Chinese patients with livedoid vasculopathy
by: Chen W, et al.
Published: (2017-03-01)

Latent opportunities for the prevention of ischemic stroke in patients with atherosclerosis-related diseases: additional analysis of randomized trials on rivaroxaban
by: S. R. Gilyarevskiy
Published: (2020-03-01)

Bullous pemphigoid‐like skin rash associated with Rivaroxaban use in a very elderly patient with multimorbidity and chronic kidney disease: A case report
by: Shakil Ahmed Chohan, et al.
Published: (2020-04-01)

Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study
by: Anne-Laure Sennesael, et al.
Published: (2018-11-01)

Results of the Ultrasound Study of Intracardial Hemodynamics in Patients with Ischemic Heart Disease in Combination with Arterial Hypertension and Complicated by Chronic Heart Failure 2A and 2B
by: Nina Matsegora, et al.
Published: (2017-10-01)

Clopidogrel in cardiovascular disease treatment: modern clinical recommendations
by: I. S. Yavelov
Published: (2006-10-01)

A study on the role of rivaroxaban in management of venous thromboembolism
by: Mohmed Abdalwahab, et al.
Published: (2015-10-01)

Intracranial hemorrhage in patient treated with rivaroxaban
by: Michelle Molina, et al.
Published: (2014-03-01)

NOVEL APPROACH TO ANTITHROMBOTIC TREATMENT OF ACUTE CORONARY PATIENTS WITH RIVAROXABAN
by: I. N. Bokarev, et al.
Published: (2015-07-01)

Exploratory analysis of traditional risk factors of ischemic heart disease (IHD) among predominantly Malay Malaysian women
by: Norafidah Abdul Rashid, et al.
Published: (2019-06-01)

A prospective, observational study of rivaroxaban for stroke prevention in atrial fibrillation: the XANAP Korea
by: Jaemin Shim, et al.
Published: (2021-07-01)

MODERN APPROACHES TO ANTICOAGULANT THERAPY OF PULMONARY EMBOLISM: FOCUS ON RIVAROXABAN
by: O. V. Averkov, et al.
Published: (2017-11-01)

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-11-01)

Long-term rivaroxaban for the treatment of acute venous thromboembolism in patients with active cancer in a prospective multicenter trial
by: Ho-Young Yhim, et al.
Published: (2019-09-01)

Rivaroxaban for the treatment of cerebral venous thrombosis
by: Sara Esmaeili, et al.
Published: (2021-02-01)

SPONTANEOUS SPLENIC RUPTURE SECONDARY TO RIVAROXABAN: RARE BUT RAISING
by: Zainab Naseem, et al.
Published: (2016-08-01)

Applying DESyne coronary stent system in patients with ischemic heart disease: experience from Jordan
by: Jarrah MI, et al.
Published: (2018-11-01)

Prevention of heart embolic complications in atrial fibrillation: Possibilities of using rivaroxaban
by: I S Iavelov
Published: (2013-12-01)

Cancer‐associated venous thromboembolism: Treatment and prevention with rivaroxaban
by: Rupert Bauersachs, et al.
Published: (2020-05-01)

ANALYSIS OF THE TRADITIONAL RISK FACTORS INFLUENCE ON DEVELOPMENT OF ISCHEMIC HEART DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA
by: V. A. Korneva, et al.
Published: (2017-06-01)

ANALYSIS OF OUTPATIENT PHYSICIANS, PRESCRIPTION OF DISAGGREGANT THERAPY FOR PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION AND/OR CORONARY ANGIOPLASTY WITH STENT IMPLANTATION WITHIN THE RECVAD REGISTRY
by: A. V. Zagrebelnyi, et al.
Published: (2015-10-01)

Prevention of venous thromboembolism with rivaroxaban and apixaban in orthopedic surgery
by: Antonijević Nebojša, et al.
Published: (2020-01-01)

A Novel Synthesis of the Oxazolidinone Antithrombotic Agent Rivaroxaban
by: Jianyong Yuan, et al.
Published: (2014-09-01)

Application of rivaroxaban in clinical practice: results of a prospective observational study XANTUS in patients with atrial fibrillation
by: S. G. Kanorskii
Published: (2016-09-01)

Rivaroxaban in secondary prevention of cardioembolic stroke: standards and abnormal situations
by: A.V. Fonyakin, et al.
Published: (2014-05-01)

Prevalence of ACS in Avicenna Balkhi Teaching Hospital in Afghanistan
by: Mohammad Mujtaba Ghaffari, et al.
Published: (2021-07-01)

Intrahepatic Cholangiocarcinoma Associated with Intrahepatic Duct Stones
by: Hoon Hur, et al.
Published: (2009-01-01)

A patient with an acute traumatic subdural hematoma chronically treated with rivaroxaban – a challenge for neurosurgeons
by: Wojciech Czyżewski, et al.
Published: (2017-09-01)

STUDY OF A TREND IN THE FREQUENCY OF USING MAIN DRUG CLASSES INDICATED FOR THE TREATMENT OF PATIENTS WITH CHRONIC CORONARY HEART DISEASE IN 2004 TO 2014: DATA FROM THE CHD PROGNOSIS REGISTRY
by: S. N. Tolpygina, et al.
Published: (2016-06-01)

International longitudinal registry of patients with atrial fibrillation and treated with rivaroxaban: RIVaroxaban Evaluation in Real life setting (RIVER)
by: Jan Beyer-Westendorf, et al.
Published: (2019-04-01)

CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES
by: P. J. Dovgalevsky, et al.
Published: (2016-01-01)

Venous tromboembolism treatment: budget impact analysis of rivaroxaban in Italy
by: Daniela Paola Roggeri, et al.
Published: (2014-12-01)